Transcranial alternating current stimulation (tACS) is a neuromodulation procedure that is currently studied for the purpose of improving cognitive function in various diseases. A few studies have shown positive effects of tACS in Alzheimer’s disease (AD). However, the mechanism underlying tACS has not been established. The purpose of this study was to investigate the mechanism of tACS in five familial AD mutation (5xFAD) mouse models. We prepared twenty 4-month-old mice and divided them into four groups: wild-type mice without stimulation (WT-NT group), wild-type mice with tACS (WT-T group), 5xFAD mice without stimulation (AD-NT group), and 5xFAD mice with tACS (AD-T group). The protocol implemented was as follows: gamma frequency 200 μA o...
The universal failure of pharmacologic interventions against Alzheimer\u27s disease (AD) appears lar...
In 1990 a series of studies started in which the effects of Transcutaneous Electrical Nerve Stimulat...
Despite decades of research, Alzheimer’s Disease (AD) remains a lethal neurodegenerative disorder fo...
BackgroundThe main manifestation of Alzheimer’s disease (AD) in patients and animal models is impair...
The pharmacological treatment of Alzheimer’s disease (AD) is often limited and accompanied by drug s...
In the past years, major efforts have been made to understand the genetics and molecular pathogenesi...
International audienceTransgenic (Tg) mouse models of Alzheimer's disease (AD) are used to investiga...
Abstract Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal sli...
BACKGROUND: Gamma sensory stimulation may reduce AD-specific pathology. Yet, the efficacy of alterna...
BackgroundNeurogenesis is significantly impaired in the brains of both human patients and experiment...
Pathological proteins contributing to Alzheimer’s disease (AD) are known to disrupt normal neuronal ...
Objective This study aimed to assess whether non-invasive brain stimulation with transcranial altern...
Alzheimer’s disease (AD) is the main cause of dementia worldwide. Emerging non-invasive treatments s...
The 3xTg-AD mouse is a widely used model in the study of Alzheimer’s Disease (AD). It has been exten...
Alzheimer's disease (AD) is one of the most devastating conditions affecting elderly in Western Worl...
The universal failure of pharmacologic interventions against Alzheimer\u27s disease (AD) appears lar...
In 1990 a series of studies started in which the effects of Transcutaneous Electrical Nerve Stimulat...
Despite decades of research, Alzheimer’s Disease (AD) remains a lethal neurodegenerative disorder fo...
BackgroundThe main manifestation of Alzheimer’s disease (AD) in patients and animal models is impair...
The pharmacological treatment of Alzheimer’s disease (AD) is often limited and accompanied by drug s...
In the past years, major efforts have been made to understand the genetics and molecular pathogenesi...
International audienceTransgenic (Tg) mouse models of Alzheimer's disease (AD) are used to investiga...
Abstract Synaptic transmission and long-term potentiation (LTP) in the CA1 region of hippocampal sli...
BACKGROUND: Gamma sensory stimulation may reduce AD-specific pathology. Yet, the efficacy of alterna...
BackgroundNeurogenesis is significantly impaired in the brains of both human patients and experiment...
Pathological proteins contributing to Alzheimer’s disease (AD) are known to disrupt normal neuronal ...
Objective This study aimed to assess whether non-invasive brain stimulation with transcranial altern...
Alzheimer’s disease (AD) is the main cause of dementia worldwide. Emerging non-invasive treatments s...
The 3xTg-AD mouse is a widely used model in the study of Alzheimer’s Disease (AD). It has been exten...
Alzheimer's disease (AD) is one of the most devastating conditions affecting elderly in Western Worl...
The universal failure of pharmacologic interventions against Alzheimer\u27s disease (AD) appears lar...
In 1990 a series of studies started in which the effects of Transcutaneous Electrical Nerve Stimulat...
Despite decades of research, Alzheimer’s Disease (AD) remains a lethal neurodegenerative disorder fo...